The activation of TGF‐β and EGF signaling pathways plays a critical role in cancer metastasis and proliferation, respectively, where LY6K is required for TGF‐β‐ and EGF‐induced metastasis in breast cancer and glioblastoma.11, 12. This evidence concerns the gene LY6K and cancer.